These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 8239322

  • 1. Handling punctate keratitis resulting from systemic cytarabine.
    Friedland S, Loya N, Shapiro A.
    Ann Ophthalmol; 1993 Aug; 25(8):290-1. PubMed ID: 8239322
    [Abstract] [Full Text] [Related]

  • 2. Ocular toxicity from high-dose cytosine arabinoside.
    Ritch PS, Hansen RM, Heuer DK.
    Cancer; 1983 Feb 01; 51(3):430-2. PubMed ID: 6571799
    [Abstract] [Full Text] [Related]

  • 3. Thygeson's superficial punctate keratitis: ten years' experience.
    Nagra PK, Rapuano CJ, Cohen EJ, Laibson PR.
    Ophthalmology; 2004 Jan 01; 111(1):34-7. PubMed ID: 14711711
    [Abstract] [Full Text] [Related]

  • 4. Is there a relationship between cytarabine pharmacokinetics and keratitis?--A case report.
    Boos J, Bömelburg T, Gerding H, Jürgens H.
    Int J Clin Pharmacol Ther Toxicol; 1993 Dec 01; 31(12):593-6. PubMed ID: 8314360
    [Abstract] [Full Text] [Related]

  • 5. Successful administration of cytarabine in a 16-month-old girl with acute myelogenous leukemia and cytarabine syndrome.
    Metz KA, Johnson T, Hershey GK, Lierl MB, Seidu L, Burns K, Assa'ad A.
    Ann Allergy Asthma Immunol; 2009 Feb 01; 102(2):173-4. PubMed ID: 19230475
    [No Abstract] [Full Text] [Related]

  • 6. Corneal toxicity with systemic cytarabine.
    Hopen G, Mondino BJ, Johnson BL, Chervenick PA.
    Am J Ophthalmol; 1981 Apr 01; 91(4):500-4. PubMed ID: 6939330
    [Abstract] [Full Text] [Related]

  • 7. Infliximab for the treatment of refractory progressive sterile peripheral ulcerative keratitis associated with late corneal perforation: 3-year follow-up.
    Odorcic S, Keystone EC, Ma JJ.
    Cornea; 2009 Jan 01; 28(1):89-92. PubMed ID: 19092414
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the prophylactic effects of 2-deoxycytidine and prednisolone for high-dose intravenous cytarabine-induced keratitis.
    Lazarus HM, Hartnett ME, Reed MD, Murphy BF, Lass JH.
    Am J Ophthalmol; 1987 Nov 15; 104(5):476-80. PubMed ID: 3314526
    [Abstract] [Full Text] [Related]

  • 9. Severe central nervous system toxicity from high-dose cytarabine: expressive aphasia occurring after the second day of treatment.
    Watson PR, Brubaker LH, Yaghmai F.
    Cancer Treat Rep; 1985 Mar 15; 69(3):313-4. PubMed ID: 3978659
    [Abstract] [Full Text] [Related]

  • 10. Diffuse lamellar keratitis induced by toxic chemicals after laser in situ keratomileusis.
    Shen YC, Wang CY, Fong SC, Tsai HY, Lee YF.
    J Cataract Refract Surg; 2006 Jul 15; 32(7):1146-50. PubMed ID: 16857501
    [Abstract] [Full Text] [Related]

  • 11. [A phase II study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia].
    Miyawaki S, Mizoguchi H, Tomonaga M, Kanamaru A, Tsukagoshi S, Nakamura T, Ohashi Y, Yoshida S, Ohno R.
    Gan To Kagaku Ryoho; 1998 Dec 15; 25(14):2229-42. PubMed ID: 9881080
    [Abstract] [Full Text] [Related]

  • 12. Modification of 1-tyrosine-induced keratopathy by adrenal corticosteroids.
    Burns RP, Beard ME, Weimar VL, Squires EL.
    Invest Ophthalmol; 1974 Jan 15; 13(1):39-45. PubMed ID: 4149026
    [No Abstract] [Full Text] [Related]

  • 13. A phase II comparative study of idarubicin plus cytarabine versus daunorubicin plus cytarabine in adult acute myeloid leukemia.
    Masaoka T, Ogawa M, Yamada K, Kimura K, Ohashi Y.
    Semin Hematol; 1996 Oct 15; 33(4 Suppl 3):12-7. PubMed ID: 8916311
    [Abstract] [Full Text] [Related]

  • 14. Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
    Camera A, Rinaldi CR, Palmieri S, Cantore N, Mele G, Mettivier V, Miraglia E, Mastrullo L, Grimaldi F, Luciano L, Guerriero A, Rotoli B, Ferrara F.
    Ann Hematol; 2009 Feb 15; 88(2):151-8. PubMed ID: 18709502
    [Abstract] [Full Text] [Related]

  • 15. [Cytarabine-induced pericarditis].
    Yamada T, Tsurumi H, Hara T, Sawada M, Oyama M, Moriwaki H.
    Rinsho Ketsueki; 1998 Nov 15; 39(11):1115-20. PubMed ID: 9866424
    [Abstract] [Full Text] [Related]

  • 16. Keratitis and corneal scarring after UVA/riboflavin cross-linking for keratoconus.
    Koppen C, Vryghem JC, Gobin L, Tassignon MJ.
    J Refract Surg; 2009 Sep 15; 25(9):S819-23. PubMed ID: 19772258
    [Abstract] [Full Text] [Related]

  • 17. A fludarabine, topotecan, and cytarabine regimen is active in patients with refractory acute myelogenous leukemia.
    Giles FJ, Cortes JE, Kantarjian HM, O'Brien SM, Estey E, Beran M.
    Leuk Res; 2004 Apr 15; 28(4):353-7. PubMed ID: 15109534
    [Abstract] [Full Text] [Related]

  • 18. [Observation and care in high-dose cytarabine treatment of acute myelogenous leukemia].
    Xi YR, Tu YL, Zhao XH.
    Zhonghua Hu Li Za Zhi; 1996 Nov 15; 31(11):653-5. PubMed ID: 9304928
    [No Abstract] [Full Text] [Related]

  • 19. [Early phase II study of Idarubicin combined with cytarabine in acute myelogenous leukemia. Idarubicin Study Group].
    Ogawa M, Masaoka T, Yamada K, Kimura K.
    Gan To Kagaku Ryoho; 1993 May 15; 20(7):907-14. PubMed ID: 8489297
    [Abstract] [Full Text] [Related]

  • 20. Bilateral peripheral ulcerative keratitis associated with pyoderma gangrenosum.
    Bouchard CS, Meyer MA, McDonnell JF.
    Cornea; 1997 Jul 15; 16(4):480-2. PubMed ID: 9220248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.